![Judy Chou](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Judy Chou
Directeur Général chez
Altrubio, Inc.
Profil
Judy Chou is currently President, Chief Executive Officer & Director at AltruBio, Inc. since 2020.
Former positions include Independent Director at Akero Therapeutics, Inc. from 2021 to 2025, Director & Member-Governors Board at Biocom, Inc. from 2019 to 2020, and Senior Vice President & Global Head-Biotech at Bayer Pharmaceuticals.
Education includes a doctorate from Yale University.
Postes actifs de Judy Chou
| Sociétés | Poste | Début |
|---|---|---|
Altrubio, Inc.
 Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Directeur Général | 01/01/2020 |
Anciens postes connus de Judy Chou
| Sociétés | Poste | Fin |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 09/12/2025 |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Directeur/Membre du Conseil | 19/11/2020 |
Bayer Pharmaceuticals
 Bayer Pharmaceuticals Pharmaceuticals: MajorHealth Technology Operates as a pharmaceuticals company | Corporate Officer/Principal | - |
Formation de Judy Chou
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
30
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Commercial Services |
Akero Therapeutics, Inc.
 Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
Altrubio, Inc.
Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Health Technology |
Bayer Pharmaceuticals
Bayer Pharmaceuticals Pharmaceuticals: MajorHealth Technology Operates as a pharmaceuticals company | Health Technology |
